SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-013318
Filing Date
2022-05-09
Accepted
2022-05-09 16:15:40
Documents
85
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q akba-20220331.htm   iXBRL 10-Q 1960892
2 EX-10.6 exhibit106-formofofficerre.htm EX-10.6 11602
3 EX-10.7 exhibit107-formoflettermic.htm EX-10.7 61107
4 EX-10.8 exhibit108-dellseparationa.htm EX-10.8 57829
5 EX-31.1 exhibit311-q12022.htm EX-31.1 11363
6 EX-31.2 exhibit312-q12022.htm EX-31.2 11403
7 EX-32.1 exhibit321-q12022.htm EX-32.1 9271
  Complete submission text file 0001628280-22-013318.txt   8955007

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akba-20220331.xsd EX-101.SCH 86342
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT akba-20220331_cal.xml EX-101.CAL 87951
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akba-20220331_def.xml EX-101.DEF 388993
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT akba-20220331_lab.xml EX-101.LAB 778530
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akba-20220331_pre.xml EX-101.PRE 550333
79 EXTRACTED XBRL INSTANCE DOCUMENT akba-20220331_htm.xml XML 1224325
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36352 | Film No.: 22905139
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences